Afghanistan vs Qatar: Access to anti-retroviral drugs, female
Afghanistan
38.0%
in 2024
Qatar
43.0%
in 2024
Afghanistan rank
129th
Qatar rank
126th
Access to anti-retroviral drugs, female over time
- Afghanistan
- Qatar
How they compare
Qatar currently reports 43.0% against 38.0% in Afghanistan, a difference of 5.0%.
That makes Qatar's figure about 1.1 times Afghanistan's.
Across all 17 years both countries report, Qatar has been ahead every year.
Afghanistan ranks 129th and Qatar ranks 126th of 141 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 27.4% | 85.2% | 57.8% | Qatar |
| 2020s | 33.8% | 53.0% | 19.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Afghanistan or Qatar?
- Qatar, at 43.0% against 38.0% in Afghanistan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Afghanistan and Qatar?
- 5.0%, with Qatar ahead.
- How many years of comparable data are there for Afghanistan and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Qatar rank globally for access to anti-retroviral drugs, female?
- Afghanistan ranks 129th and Qatar ranks 126th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.